Yit, P. J. (2022). Evaluation of genetic alterations of IDH1, TP53 and CASP9 genes as biomarkers in glioma patients.
Chicago Style (17th ed.) CitationYit, Pua Jing. Evaluation of Genetic Alterations Of IDH1, TP53 and CASP9 Genes As biomarkers in Glioma Patients. 2022.
MLA (9th ed.) CitationYit, Pua Jing. Evaluation of Genetic Alterations Of IDH1, TP53 and CASP9 Genes As biomarkers in Glioma Patients. 2022.
Warning: These citations may not always be 100% accurate.